iSpecimen (ISPC) Competitors $3.45 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$3.69 +0.24 (+6.96%) As of 05/22/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ISPC vs. GFAI, SFHG, AWX, STFS, and NOTVShould you buy iSpecimen stock or one of its competitors? MarketBeat compares iSpecimen with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iSpecimen include Guardforce AI (GFAI), Samfine Creation Holdings Group (SFHG), Avalon (AWX), Star Fashion Culture (STFS), and Inotiv (NOTV). These companies are all part of the "business services" industry. ISPC vs. GFAIISPC vs. SFHGISPC vs. AWXISPC vs. STFSISPC vs. NOTVHow does iSpecimen compare to Guardforce AI?Guardforce AI (NASDAQ:GFAI) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings. Is GFAI or ISPC more profitable? Guardforce AI has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Guardforce AI's return on equity of 0.00% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets Guardforce AIN/A N/A N/A iSpecimen -1,080.16%-584.65%-142.48% Which has more volatility & risk, GFAI or ISPC? Guardforce AI has a beta of 2.58, indicating that its stock price is 158% more volatile than the broader market. Comparatively, iSpecimen has a beta of 1.75, indicating that its stock price is 75% more volatile than the broader market. Which has stronger valuation and earnings, GFAI or ISPC? Guardforce AI has higher revenue and earnings than iSpecimen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardforce AI$35.23M0.33-$6.66MN/AN/AiSpecimen$1.03M4.82-$10.49M-$72.26N/A Do analysts recommend GFAI or ISPC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardforce AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do insiders & institutionals hold more shares of GFAI or ISPC? 2.0% of Guardforce AI shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 76.7% of Guardforce AI shares are owned by company insiders. Comparatively, 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media prefer GFAI or ISPC? In the previous week, Guardforce AI had 1 more articles in the media than iSpecimen. MarketBeat recorded 1 mentions for Guardforce AI and 0 mentions for iSpecimen. Guardforce AI's average media sentiment score of 0.00 beat iSpecimen's score of -0.95 indicating that Guardforce AI is being referred to more favorably in the media. Company Overall Sentiment Guardforce AI Neutral iSpecimen Negative SummaryGuardforce AI beats iSpecimen on 9 of the 11 factors compared between the two stocks.How does iSpecimen compare to Samfine Creation Holdings Group?iSpecimen (NASDAQ:ISPC) and Samfine Creation Holdings Group (NASDAQ:SFHG) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends. Do analysts prefer ISPC or SFHG? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Samfine Creation Holdings Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do institutionals and insiders hold more shares of ISPC or SFHG? 13.6% of iSpecimen shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to ISPC or SFHG? In the previous week, Samfine Creation Holdings Group's average media sentiment score of 0.00 beat iSpecimen's score of -0.95 indicating that Samfine Creation Holdings Group is being referred to more favorably in the news media. Company Overall Sentiment iSpecimen Negative Samfine Creation Holdings Group Neutral Is ISPC or SFHG more profitable? Samfine Creation Holdings Group has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Samfine Creation Holdings Group's return on equity of 0.00% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets iSpecimen-1,080.16% -584.65% -142.48% Samfine Creation Holdings Group N/A N/A N/A Which has more risk and volatility, ISPC or SFHG? iSpecimen has a beta of 1.75, meaning that its share price is 75% more volatile than the broader market. Comparatively, Samfine Creation Holdings Group has a beta of 2.09, meaning that its share price is 109% more volatile than the broader market. Which has stronger earnings and valuation, ISPC or SFHG? Samfine Creation Holdings Group has higher revenue and earnings than iSpecimen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiSpecimen$1.03M4.82-$10.49M-$72.26N/ASamfine Creation Holdings Group$21.82M0.47-$2.55MN/AN/A SummarySamfine Creation Holdings Group beats iSpecimen on 7 of the 10 factors compared between the two stocks.How does iSpecimen compare to Avalon?Avalon (NYSE:AWX) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Does the media refer more to AWX or ISPC? In the previous week, Avalon had 1 more articles in the media than iSpecimen. MarketBeat recorded 1 mentions for Avalon and 0 mentions for iSpecimen. Avalon's average media sentiment score of 1.16 beat iSpecimen's score of -0.95 indicating that Avalon is being referred to more favorably in the media. Company Overall Sentiment Avalon Positive iSpecimen Negative Which has more volatility and risk, AWX or ISPC? Avalon has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.75, indicating that its stock price is 75% more volatile than the broader market. Do insiders and institutionals believe in AWX or ISPC? 34.4% of Avalon shares are held by institutional investors. Comparatively, 13.6% of iSpecimen shares are held by institutional investors. 20.0% of Avalon shares are held by company insiders. Comparatively, 12.2% of iSpecimen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has better earnings & valuation, AWX or ISPC? Avalon has higher revenue and earnings than iSpecimen. iSpecimen is trading at a lower price-to-earnings ratio than Avalon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvalon$85.14M0.12-$1.77M$0.1517.27iSpecimen$1.03M4.82-$10.49M-$72.26N/A Is AWX or ISPC more profitable? Avalon has a net margin of 1.17% compared to iSpecimen's net margin of -1,080.16%. Avalon's return on equity of 2.72% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets Avalon1.17% 2.72% 1.10% iSpecimen -1,080.16%-584.65%-142.48% Do analysts prefer AWX or ISPC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avalon 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryAvalon beats iSpecimen on 11 of the 14 factors compared between the two stocks.How does iSpecimen compare to Star Fashion Culture?iSpecimen (NASDAQ:ISPC) and Star Fashion Culture (NASDAQ:STFS) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation. Do analysts rate ISPC or STFS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Star Fashion Culture 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is ISPC or STFS more profitable? Star Fashion Culture has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Star Fashion Culture's return on equity of 0.00% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets iSpecimen-1,080.16% -584.65% -142.48% Star Fashion Culture N/A N/A N/A Which has more volatility and risk, ISPC or STFS? iSpecimen has a beta of 1.75, suggesting that its share price is 75% more volatile than the broader market. Comparatively, Star Fashion Culture has a beta of -0.04, suggesting that its share price is 104% less volatile than the broader market. Do insiders & institutionals believe in ISPC or STFS? 13.6% of iSpecimen shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better valuation and earnings, ISPC or STFS? iSpecimen has higher earnings, but lower revenue than Star Fashion Culture. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiSpecimen$1.03M4.82-$10.49M-$72.26N/AStar Fashion Culture$120.79M0.07-$18.26MN/AN/A Does the media refer more to ISPC or STFS? In the previous week, Star Fashion Culture had 2 more articles in the media than iSpecimen. MarketBeat recorded 2 mentions for Star Fashion Culture and 0 mentions for iSpecimen. Star Fashion Culture's average media sentiment score of 0.00 beat iSpecimen's score of -0.95 indicating that Star Fashion Culture is being referred to more favorably in the news media. Company Overall Sentiment iSpecimen Negative Star Fashion Culture Neutral SummaryStar Fashion Culture beats iSpecimen on 6 of the 11 factors compared between the two stocks.How does iSpecimen compare to Inotiv?Inotiv (NASDAQ:NOTV) and iSpecimen (NASDAQ:ISPC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation. Do institutionals and insiders believe in NOTV or ISPC? 18.2% of Inotiv shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 7.8% of Inotiv shares are owned by insiders. Comparatively, 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is NOTV or ISPC more profitable? Inotiv has a net margin of -17.14% compared to iSpecimen's net margin of -1,080.16%. Inotiv's return on equity of -56.77% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets Inotiv-17.14% -56.77% -8.91% iSpecimen -1,080.16%-584.65%-142.48% Do analysts recommend NOTV or ISPC? Inotiv currently has a consensus price target of $1.50, indicating a potential upside of 455.56%. Given Inotiv's stronger consensus rating and higher probable upside, equities analysts clearly believe Inotiv is more favorable than iSpecimen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inotiv 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Does the media refer more to NOTV or ISPC? In the previous week, Inotiv's average media sentiment score of 0.00 beat iSpecimen's score of -0.95 indicating that Inotiv is being referred to more favorably in the media. Company Overall Sentiment Inotiv Neutral iSpecimen Negative Which has more risk & volatility, NOTV or ISPC? Inotiv has a beta of 3.82, suggesting that its stock price is 282% more volatile than the broader market. Comparatively, iSpecimen has a beta of 1.75, suggesting that its stock price is 75% more volatile than the broader market. Which has preferable earnings & valuation, NOTV or ISPC? iSpecimen has lower revenue, but higher earnings than Inotiv. Inotiv is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInotiv$513.02M0.02-$68.62M-$2.53N/AiSpecimen$1.03M4.82-$10.49M-$72.26N/A SummaryInotiv beats iSpecimen on 11 of the 15 factors compared between the two stocks. Get iSpecimen News Delivered to You Automatically Sign up to receive the latest news and ratings for ISPC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ISPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ISPC vs. The Competition ExportMetriciSpecimenMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.96M$8.38B$6.43B$12.32BDividend YieldN/A2.98%2.76%5.28%P/E Ratio-0.0521.2721.0125.66Price / Sales4.8224.28615.84111.99Price / CashN/A86.2043.4956.67Price / Book6.055.8410.377.14Net Income-$10.49M$183.47M$3.57B$335.98M7 Day Performance-12.21%65.57%6.01%3.56%1 Month Performance-33.86%49.96%3.52%2.54%1 Year Performance-91.94%4.53%34.13%35.05% iSpecimen Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ISPCiSpecimen0.3579 of 5 stars$3.45flatN/A-91.9%$4.96M$1.03MN/A60Gap UpGFAIGuardforce AI0.7407 of 5 stars$0.49+3.6%N/A-58.2%$11.54M$35.23MN/A1,604Analyst UpgradeGap UpSFHGSamfine Creation Holdings Group0.4616 of 5 stars$2.50+0.4%N/A-43.8%$10.11M$21.82MN/AN/AAWXAvalonN/A$2.57-1.0%N/A+7.2%$10.00M$85.14M10.26610News CoveragePositive NewsSTFSStar Fashion Culture0.6431 of 5 stars$7.51-6.1%N/A-84.4%$9.55M$16.86MN/A22Gap Up Related Companies and Tools Related Companies GFAI Competitors SFHG Competitors AWX Competitors STFS Competitors NOTV Competitors DTST Competitors TGHL Competitors OFAL Competitors WWAC Competitors BIAF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ISPC) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
